1. Home
  2. Flashcards
  3. Preview

Therapeutics II Top 200 - Endocrinology Cardiovascular_Renal Dermatology Respiratory

  1. glimepiride

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Amaryl
    • 2. 2nd generation sulfonylurea
    • 3. Type II Diabetes Mellitus
    • 4. inhibit ATP-K+ channels in pancreas, causing Ca2+ channel activation/influx that releases insulin
    • 5. 1-2 mg once daily; 8mg per day, max dose
    • 6. ACEi, Beta- Blockers, Fluoroquinolones
  2. glipizide IR, ER

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Glucotrol, Glucotrol XL
    • 2. 2nd generation sulfonylurea
    • 3. Type 2 Diabetes Mellitus
    • 4. Therapeutics II Top 200 - Endocrinology  Cardiovascular_Renal  Dermatology  Respiratory
    • 5. 5 mg po qd before breakfast
    • 6. ACEi, Beta- Blockers, Fluoroquinolones
  3. glyburide IR

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Diabeta
    • 2. 2nd generation sulfonylurea
    • 3. Type 2 Diabetes Mellitus
    • 4. inhibit ATP-K+ channels in pancreas, causing Ca2+ channel activation/influx that releases insulin
    • 5. initial 2.5 mg to 5 mg po qd, or 2 divided doses; max 5 mg/day. Maintenance 1.5 to 20 mg; Max 20 mg/day
    • 6. BEERS List; ACEi, Beta- Blockers, Fluoroquinolones
  4. insulin glargine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lantus
    • 2. antidiabetic
    • 3. Type 1 & 2 Diabetes Mellitus
    • 4. Regulates glucose metabolism; stimulates glucose uptake my muscles and fat; inhibits lipolysis and proteolysis; enhances protein synthesis
    • 5. Type 1: initial 1/3 of total daily dose QD then titrate to glucose reading; Type 2: 10 units QD (0.2 units/kg) then titrate to glucose reading
    • 6.
  5. levothyroxine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Synthroid
    • 2. thyroid function
    • 3. Hypothyroidsim
    • 4. Synthetic T4 (thyroxine) is converted to active T3 stimulate thyroid receptors in cell nucleus
    • 5. In otherwise healthy, 1.7 mcg/kg/day (100 - 125 mcg for 70kg adult); w/ cardiac disease, 25 - 50 mcg; elderly w/ cardiac disease, 12.5 - 25 mcg/day and increase until TSH normalizes; in severe hypothyroidsm, 12.5 to 25 mcg/day until TSH normalizes
    • 6. Black Box: Not used for weight loss, severe toxicity
  6. metformin IR, ER

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Glucophage, Glucophage XR
    • 2. biguanide
    • 3. Type 2 Diabetes Mellitus; Polycystic Ovary Syndrome
    • 4.
    • 5.
    • 6.
  7. phentermine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Adipex-P, Lomaira
    • 2. antiobesity agent
    • 3. Obesity
    • 4.
    • 5.
    • 6.
  8. sitagliptan

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Januvia
    • 2. Dipeptidyl Peptidase V inhibitor
    • 3. Type 2 Diabetes Mellitus
    • 4.
    • 5.
    • 6.
  9. amlodipine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Norvasc
    • 2. antihypertensive
    • 3. HTN, stable angina, Reynaud's, Silent MI
    • 4.
    • 5.
    • 6.
  10. amlodipine/benazepril

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lotrel
    • 2. ACEi/Calcium channel blocker
    • 3. HTN
    • 4.
    • 5.
    • 6.
  11. aspirin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Ecotrin
    • 2. NSAID, Salicylate
    • 3. Fever, headache, Migraine, Pain, Afib, MI, Thromboembolism
    • 4.
    • 5.
    • 6.
  12. atenolol

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Tenormin
    • 2. Beta-blocker 1 selective, antihypertensive
    • 3. HTN, Afib (Rate control)
    • 4.
    • 5.
    • 6.
  13. atorvastatin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lipitor
    • 2. antilipemic, HMG-CoA Reductase inhibitor
    • 3. Hyperlipidemia, Hypercholesteremia
    • 4.
    • 5.
    • 6.
  14. benazepril

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lotensin
    • 2. ACE inhibitor, antihypertensive
    • 3. HTN
    • 4.
    • 5.
    • 6.
  15. carvedilol IR

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Coreg
    • 2. Non-selective beta blocker w/ alpha 1 activity
    • 3. HTN, HF, LV following MI, Afib (Rate control)
    • 4.
    • 5.
    • 6.
  16. clonidine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Catapres
    • 2. alpha-2 adrenergic agonist, antihypertensive
    • 3. HTN, opioid withdrawal
    • 4.
    • 5.
    • 6.
  17. clopidogrel

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Plavix
    • 2. Thienopyradine, Antiplatelet
    • 3. ACS, CAD, Afib, CABG
    • 4.
    • 5.
    • 6.
  18. diltiazem

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Cardizem
    • 2. Non-dihydropyradine calcium channel blocker
    • 3. Angina, HTN, Afin/Aflutter (rate control), SVT
    • 4.
    • 5.
    • 6.
  19. enalapril

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Vasotec
    • 2. ACE inhibitor, antihypertensive
    • 3. HTN, HF, asymptomatic LV
    • 4.
    • 5.
    • 6.
  20. enoxaparin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lovenox
    • 2. Low Molecular Weight Heparin, Anticoagulant
    • 3. DVT, STEMI, Unstable angina (NSTEMI)
    • 4.
    • 5.
    • 6.
  21. ezetimibe

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Zetia
    • 2. Antilipemic agent
    • 3. Homozygous Familial Hypercholesteremia, Primary Hyperlipidemia
    • 4.
    • 5.
    • 6.
  22. fenofibrate/fenofibric acid

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Tricor
    • 2. Antilipemic Agent, Fibric Acid
    • 3. Hypertriglyceridemia, Hyperlipidemia, Hypercholesteremia
    • 4.
    • 5.
    • 6.
  23. folic acid

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Apo-folic
    • 2. Vitamin
    • 3. Megaloblastic Anemia, neural tube defects
    • 4.
    • 5.
    • 6.
  24. furosemide

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lasix
    • 2. Loop diuretic, antihypertensive
    • 3. Edema/HF, Acute Pulmonary Edema, Ascites
    • 4.
    • 5.
    • 6.
  25. heparin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Unfractionated Heparin
    • 2. Anticoagulant
    • 3. ACS, Afib, Venous thromboembolism, thromboprophylaxis
    • 4.
    • 5.
    • 6.
  26. hydralazine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Apresoline
    • 2. Vasodilator
    • 3. HTN, HF
    • 4.
    • 5.
    • 6.
  27. hydrochlorothiazide

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Microzide
    • 2. Diuretic, thiazide
    • 3. Edema, HTN
    • 4.
    • 5.
    • 6.
  28. isosorbide mononitrate

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Imdur
    • 2. Vasodilator
    • 3. Angina pectoris
    • 4.
    • 5.
    • 6.
  29. lisinopril

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Prinivil, Zestril
    • 2. ACE inhibitor
    • 3. Acute MI, HF, HTN
    • 4.
    • 5.
    • 6.
  30. lisinopril/hydrochlorothiazide

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Zestoretic
    • 2. ACE inhibitor/Thiazide Diuretic
    • 3. HTN
    • 4.
    • 5.
    • 6.
  31. losartan

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Cozaar
    • 2. ARB, antihypertensive
    • 3. HTN, Diabtetic neuropathy, HTN- w/ LV dysfunction, HF
    • 4.
    • 5.
    • 6.
  32. losartan/hydrochlorothiazide

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Hyzaar
    • 2. ARB/Thiazide Diuretic
    • 3. HTN, HTN- w/ LV hypertrophy
    • 4.
    • 5.
    • 6.
  33. lovastatin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Mevacor
    • 2. Antilipemic agent, HMG-CoA reductase inhibitor
    • 3. Dyslipidemia, primary prevention of CAD and ASCVD
    • 4.
    • 5.
    • 6.
  34. metoprolol succinate

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Toprol XL
    • 2. Beta blocker 1 selective, antihypertensive, antianginal agent
    • 3. Angina, Afib/flutter (ventricular rate control), HF, HTN, MI, SVT
    • 4.
    • 5.
    • 6.
  35. metoprolol tartrate

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lopressor
    • 2. Beta blocker 1 selective, antihypertensive, antianginal agent
    • 3. Angina, Afib/flutter (ventricular rate control), HF, HTN, MI, SVT
    • 4.
    • 5.
    • 6.
  36. nebivolol

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Bystolic
    • 2. Beta blocker 1 selective
    • 3. HTN, CABG, Ischemic Heart Disease, Valvular Heart Disease
    • 4.
    • 5.
    • 6.
  37. potassium chloride

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Klor-Con
    • 2. Electrolyte Supplement
    • 3. Hypokalemia
    • 4.
    • 5.
    • 6.
  38. pravastatin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Pravachol
    • 2. Anti Lipemic Agent, HMG-CoA Reductase Inhibitor
    • 3. Hyperlipidemia, prevention of primary and secondary cardiac events
    • 4.
    • 5.
    • 6.
  39. propranolol LA/XL

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Inderal LA, Inderal XL
    • 2. Beta Blocker Non-Selective, Antiarrhythmic, Antianginal agent
    • 3.
    • 4.
    • 5.
    • 6.
  40. ramipril

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Altace
    • 2. ACE inhibitor, Antihypertensive
    • 3. HF, HTN, reduction of MI/Stroke
    • 4.
    • 5.
    • 6.
  41. rivaroxaban

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Xarelto
    • 2. Factor Xa Inhibitor, Anticoagulant
    • 3. DVT, reduction of risk of DVT/PE
    • 4.
    • 5.
    • 6.
  42. rosuvastatin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Crestor
    • 2. HMG-CoA Reductase Inhibitor, Anti Lipemic Agent
    • 3. Hyperlipidemia, Hypertriglyceridemia, Homozygous familial hypercholesterolemia
    • 4.
    • 5.
    • 6.
  43. simvastatin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Zocor
    • 2. HMG-CoA Reductase Inhibitor, Anti Lipemic Agent
    • 3. Homozygous Familial Cholesteremia, Hyperlipidemia
    • 4.
    • 5.
    • 6.
  44. spironolactone

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Aldactone
    • 2. K+ sparing Loop Diuretic
    • 3. Edema, hypokalemia, HF, diagnosis of primary alodsteronism, Hirsutism in women (off-label)
    • 4.
    • 5.
    • 6.
  45. triamterene/hydrochlorothiazide

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Maxzide
    • 2. Antihypertensive, Potassium sparing thiazide diuretic
    • 3. HTN, Edema
    • 4.
    • 5.
    • 6.
  46. valsartan

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Diovan
    • 2. ARB, Antihypertensive
    • 3. HTN, HF, LV dysfunction or MI
    • 4.
    • 5.
    • 6.
  47. valsartan/HCTZ

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Diovan HCT
    • 2. ARB, Diuretic Thiazide, Antihypertensive
    • 3. HTN
    • 4.
    • 5.
    • 6.
  48. warfarin

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Coumadin
    • 2. Vitamin K Antagonist, Anticoagulant
    • 3. Thromboembolism, MI
    • 4.
    • 5.
    • 6.
  49. albuterol HFA

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Pro-Air, Proventil, Ventolin
    • 2. Beta 2 Agonist, Bronchodilator
    • 3. Asthma, Bronchospasm, COPD, Hyperkalemia (off label)
    • 4.
    • 5.
    • 6.
  50. benzonatate

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Tessalon Perles
    • 2. Antitussive
    • 3. Cough
    • 4.
    • 5.
    • 6.
  51. cetirizine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Zyrtec
    • 2. 2nd gen. Histamine H1 Antagonist
    • 3. Upper respiratory allergies, Urticaria,
    • 4.
    • 5.
    • 6.
  52. dextromethorphan

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1.
    • 2. Delsym
    • 3. Antitussive, N-Methyl-D-Aspartate Receptor Agonist
    • 4.
    • 5.
    • 6.
  53. diphenhydramine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Benadryl
    • 2. 1st gen. Histamine H1 Antagonist
    • 3. Allergic reactions, Antitussive, Motion Sickness, Occasional, Insomnia, Parkinsonism, Rhinitis- sneezing due to cold, Anaphylaxis (adjunct to epinephrine - off label)
    • 4.
    • 5.
    • 6.
  54. fluticasone HFA

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Flovent
    • 2. Corticosteroid
    • 3. Asthma
    • 4.
    • 5.
    • 6.
  55. fluticasone propionate

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Flonase Allergy Relief
    • 2. Corticosteroid
    • 3. Non-Allergic Rhinitis, upper respiratory allergies
    • 4.
    • 5.
    • 6.
  56. fluticasone/salmeterol Diskus

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Advair Diskus, Advair HFA
    • 2. Beta 2 Adrenergic Agonist, Long Acting, Corticosteroid
    • 3.
    • 4.
    • 5.
    • 6.
  57. formoterol/budesonide

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Symbicort
    • 2. Beta 2 Adrenergic Agonist, Long Acting
    • 3. Asthma, COPD
    • 4.
    • 5.
    • 6.
  58. guaifensen IR, ER

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Mucinex
    • 2. Expectorant
    • 3. Cough (expectorant)
    • 4.
    • 5.
    • 6.
  59. ketotifen

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Alaway, Zaditor
    • 2. 2nd gen. Histamine H1 Antagonist, Mast Cell Stabilizer
    • 3. Allergic conjunctivitis
    • 4.
    • 5.
    • 6.
  60. loratadine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Claritin
    • 2. 2nd gen. Histamine H1 antagonist
    • 3. Seasonal Allergic Rhinitis, Urticaria
    • 4.
    • 5.
    • 6.
  61. mometasone

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Nasonex
    • 2. Corticosteroid
    • 3. Allergic Rhinitis, Nasal Congestion, Nasal Polyps
    • 4.
    • 5.
    • 6.
  62. montelukast

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Singulair
    • 2. Leukotriene Receptor Antagonist
    • 3. Allergic Rhinitis, Asthma, Bronchoconstriction, Chronic Urticaria and NSIAD induced Urticaria (off label)
    • 4.
    • 5.
    • 6.
  63. oxymetazoline

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Vicks Sinex 12HR Decongestant, Afrin 12HR
    • 2. Adrenergic Agonist, Decongestant
    • 3. Nasal Congestion
    • 4.
    • 5.
    • 6.
  64. phenylephrine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Non-Pseudo Sinus Decongestant, Sudafed PE Children's
    • 2. Alpha Adrenergic Agonist
    • 3. HYPO-tension/Shock, Nasal congestion, Priaprism (off label)
    • 4.
    • 5.
    • 6.
  65. pseudoephedrine

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Sudafed
    • 2. Alpha/Beta Agonist, Decongestant
    • 3. Nasal Congestion
    • 4.
    • 5.
    • 6.
  66. tiotropium Handihaler

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Spiriva HandiHaler
    • 2. Anticholinergic Agent, Long Acting
    • 3. COPD
    • 4.
    • 5.
    • 6.
  67. triamcinolone nasal

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Nasacort Allergy 24HR
    • 2. Corticosteroid
    • 3. Allergic Rhinitis/upper respiratory symptoms, Acute Bacterial Rhinosinusitis, adjunct to antibiotics (empiric treatment)
    • 4.
    • 5.
    • 6.
  68. clobetasol

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Cormax, Temovate, Embeline
    • 2. Anti-inflammatory Agent
    • 3. Psoriasis, steroid responsive dermatoses
    • 4.
    • 5.
    • 6.
  69. hydrocortisone topical

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Aquanil, Cortaid (and many more)
    • 2. Corticosteroid, Antihemorrhoidal Agent
    • 3. Dermatoses, Atopic Dermatitis, Anal and Genital itching
    • 4.
    • 5.
    • 6.
  70. hydroxyzine HCl

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Vistaril
    • 2. Antiemetic, 1st gen. Histamine H1 Antagonist
    • 3. N/V, Anxiety, Pruritis
    • 4.
    • 5.
    • 6.
  71. miconazole topical

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lotrimin, Vagistat
    • 2. Antifungal Agent
    • 3. Tinea-pedis, -corporis, -cruris, and Vulvovaginal candiasis
    • 4.
    • 5.
    • 6.
  72. nystatin topical

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Nystop, Nyamyc
    • 2. Antifungal Agent
    • 3. Fungal infections (cutaneous and mucocutyaneous)
    • 4.
    • 5.
    • 6.
  73. terbinafine topical

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Lamisil
    • 2. Antifungal Agent
    • 3. Tinea-pedis, -corporis, -cruris, -versicolor, and Cutaneous candiasis
    • 4.
    • 5.
    • 6.
  74. triamcinolone topical

    1. Brand
    2. Class
    3. Indication
    4. MOA
    5. Dose
    6. ADR/ADE/Major DDI
    • 1. Kenalog, Oralone, Triderm
    • 2. corticosteroid
    • 3. Dermatoses, ulcerative lesions
    • 4.
    • 5.
    • 6.
Author
mbailey585
ID
326462
Card Set
Therapeutics II Top 200 - Endocrinology Cardiovascular_Renal Dermatology Respiratory
Description
Therapeutics II Top 200 - Endocrinology Cardiovascular/Renal Dermatology Respiratory
Updated

  1. Home
  2. Flashcards
  3. Preview